Successful resumption of peritoneal dialysis following living donor liver transplantation in children with end‐stage renal disease

Hiroyuki Kanazawa(National Center For Child Health and Development), Mureo Kasahara(National Center For Child Health and Development), Vidyadhar Padmakar Mali(National Center For Child Health and Development), Seisuke Sakamoto(National Center For Child Health and Development), Shingo Ishimori(Kobe University), Kenji Ishikura(Kitasato University), Hajime Uchida(National Center For Child Health and Development), Mai Sato(Kyoto University), Kengo Sasaki(National Center For Child Health and Development), Takanobu Shigeta(National Center For Child Health and Development), Akinari Fukuda(National Center For Child Health and Development)
Pediatric Transplantation
February 18, 2017
10.1111/petr.12897
Cited by 4

Related Papers

Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial
|The Lancet|2014|450
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome
|Pediatric Nephrology|2022|278
Creatinine-based equation to estimate the glomerular filtration rate in Japanese children and adolescents with chronic kidney disease
|Clinical and Experimental Nephrology|2013|267
Epidemiology of pediatric chronic kidney disease/kidney failure: learning from registries and cohort studies
|Pediatric Nephrology|2021|149
A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatment
|Kidney International|2014|135